State of the Art: Diagnosis and Treatment Strategies for Hepatocellular Carcinoma
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Gastroenterology & Hepatopancreatobiliary Medicine".
Deadline for manuscript submissions: 31 October 2024 | Viewed by 47
Special Issue Editor
Interests: hepatocellular carcinoma; diagnosis; treatment; precision medicine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are very pleased to announce our proposal of a Special Issue, entitled “State of the Art: Diagnosis and Treatment Strategies for Hepatocellular Carcinoma”. Clinical diagnosis of hepatocellular carcinoma (HCC) is mainly made on the basis of laboratory tests and radiological imaging. However, we occasionally experience several HCC patients who do not fulfill these criteria. Other techniques are required to diagnose such patients. On the other hand, a therapeutic algorithm for HCC has been proposed depending on tumor status (size, number and location) and hepatic reserve. The development of immune checkpoint inhibitors has dramatically improved the treatment outcomes. However, the current treatment is not fully personalized compared to those in other types of cancers. Nutritional intervention is also necessary for HCC patients with cachexia and/or sarcopenia.
This Special Issue focuses on the current topics regarding the clinical diagnosis of HCC, including novel tumor markers, circulating tumor cells and radiological imaging. Novel studies on precision medicine or nutritional intervention for HCC patients are also welcome for this Special Issue.
We look forward to the submission of many interesting manuscripts, including original articles and review articles.
Prof. Dr. Takashi Himoto
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- hepatocellular carcinoma
- diagnosis
- treatment
- precision medicine
